Opinion Human Leukocyte Antigen (HLA) at the Root of Persistent Antigens and Long COVID, 2025, Georgopoulos et al

Human Leukocyte Antigen (HLA) at the Root of Persistent Antigens and Long COVID

Apostolos P. Georgopoulos, Lisa M. James, Phillip K. Peterson

(Line break added)

Abstract
Here we offer a perspective on recent findings of persistent SARS-CoV-2 antigens in Long COVID through the lens of immunogenetic risk and protection, namely in the context of the fundamental role of Human Leukocyte Antigen (HLA) in eliminating viral infections. Specifically, we attribute the persistence of viral antigens to the lack or weak protection conferred by HLA against SARS-CoV-2 in individuals carrying HLA alleles with low binding affinities to the virus.

We suggest that determining the HLA Class I and II makeup of Long COVID patients will provide valuable new information in elucidating the cause for antigen persistence underlying the development of Long COVID and pave the way for successful interventions.

Link | PDF (Journal of Immunological Sciences) [Open Access]

 

9. Jutras BL, Lochhead RB, Kloos ZA, et al. Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis. Proc Natl Acad Sci U S A. 2019;116(27):13498–507. Available from: https://doi.org/10.1073/pnas.1904170116.

10. James LM, Carpenter AF, Engdahl BE, et al. Anthrax vaccination, Gulf War Illness, and Human Leukocyte Antigen (HLA). Vaccines (Basel). 2024;12(6):613. Available from: https://doi.org/10.3390/vaccines12060613.

11. James LM, Georgopoulos AP. At the root of 3 "Long" Diseases: Persistent antigens inflicting chronic damage on the brain and other organs in Gulf War Illness, Long-COVID-19, and chronic fatigue syndrome. Neurosci Insights. 2022;17:26331055221114817. Available from: https://doi.org/10.1177/26331055221114817.